Adjuvant immunotherapy with BCG of acute myeloid leukemia: a 15-year follow-up.
Reizenstein
P
P
D001500:BCG Vaccine / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic
D001500:BCG Vaccine